Prognostic importance of the expression of CD44 splice variants in oral squamous cell carcinomas

被引:36
作者
Stoll, C
Baretton, G
Soost, F
Terpe, HJ
Domide, P
Löhrs, U
机构
[1] Humboldt Univ, Dept Oral & Maxillofacial Surg, D-10117 Berlin, Germany
[2] Univ Munich, Inst Pathol, D-80337 Munich, Germany
[3] Univ Munster, Inst Pathol, D-48149 Munster, Germany
来源
ORAL ONCOLOGY | 1999年 / 35卷 / 05期
关键词
oral; squamous cell carcinoma; metastasis; CD44; variants; grading; prognosis; immunohistochemistry;
D O I
10.1016/S1368-8375(99)00021-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Considering squamous cell carcinomas (SCCs) of the oral cavity and oropharynx the molecular mechanisms underlying the infiltration and destruction of adjacent tissue as well as the metastatic spread are largely unknown. In this context, the detection of defective expression of cellular adhesion molecules in the tumour cells, e.g. CD44, might be important and correlated with prognosis. Paraffin-embedded tumour-tissue from 99 patients with primary oral and oropharyngeal SCC, additionally including corresponding lymph-node metastases in nine cases, was analysed for expression of the CD44 splice variants v4, v5, v6, v7, and v9 by means of immunohistochemistry. A diminution of at least one of the examined CD44 isoforms compared to the normal oral epithelium was observed in 39.4% of the squamous cell carcinomas. No correlations could be found between CD44 expression and pT- or pN-stage. However, decreased expression of v9 was correlated with higher histological grade (p < 0.001). Moreover, reduced CD44 expression was a statistically significant independent predictor for shorter survival time (p = 0.002) as well as shorter recurrence-free interval (p = 0.004) in addition to pT- and pN-stage. The separate analysis showed that particularly the decreased v7 (p = 0.04) and v9 (p < 0.02) expression in the tumour cells was associated negatively with survival. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:484 / 489
页数:6
相关论文
共 51 条
[1]  
[Anonymous], 1997, UICC TNM CLASSIFICAT
[2]  
Bier J., 1982, DTSCH Z MUND KIEFER, V6, P369
[3]  
BIRCH M, 1991, CANCER RES, V51, P6660
[4]   HUMAN KERATINOCYTES EXPRESS A NEW CD44 CORE PROTEIN (CD44E) AS A HEPARAN-SULFATE INTRINSIC MEMBRANE PROTEOGLYCAN WITH ADDITIONAL EXONS [J].
BROWN, TA ;
BOUCHARD, T ;
STJOHN, T ;
WAYNER, E ;
CARTER, WG .
JOURNAL OF CELL BIOLOGY, 1991, 113 (01) :207-221
[5]   EVALUATION OF CD44 PROGNOSTIC VALUE IN NEUROBLASTOMA - COMPARISON WITH THE OTHER PROGNOSTIC FACTORS [J].
COMBARET, V ;
LASSET, C ;
FRAPPAZ, D ;
BOUVIER, R ;
THIESSE, P ;
REBILLARD, AC ;
PHILIP, T ;
FAVROT, MC .
EUROPEAN JOURNAL OF CANCER, 1995, 31A (04) :545-549
[6]   IMMUNOENZYMATIC LABELING OF MONOCLONAL-ANTIBODIES USING IMMUNE-COMPLEXES OF ALKALINE-PHOSPHATASE AND MONOCLONAL ANTI-ALKALINE PHOSPHATASE (APAAP COMPLEXES) [J].
CORDELL, JL ;
FALINI, B ;
ERBER, WN ;
GHOSH, AK ;
ABDULAZIZ, Z ;
MACDONALD, S ;
PULFORD, KAF ;
STEIN, H ;
MASON, DY .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1984, 32 (02) :219-229
[7]  
COX DR, 1972, J R STAT SOC B, V34, P187
[8]   COMPARISON OF IMMUNOHISTOCHEMISTRY AND RT-PCR FOR DETECTION OF CD44V-EXPRESSION, A NEW PROGNOSTIC FACTOR IN HUMAN BREAST-CANCER [J].
DALL, P ;
HEIDER, KH ;
SINN, HP ;
SKROCHANGEL, P ;
ADOLF, G ;
KAUFMANN, M ;
HERRLICH, P ;
PONTA, H .
INTERNATIONAL JOURNAL OF CANCER, 1995, 60 (04) :471-477
[9]   An aggressive subtype of B-CLL is characterized by strong CD44 expression and lack of CD11c [J].
Eisterer, W ;
Hilbe, W ;
Stauder, R ;
Bechter, O ;
Fend, F ;
Thaler, J .
BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 (03) :661-669
[10]  
FRIEDRICHS K, 1995, CANCER RES, V55, P5424